A REAL WORLD REGISTRY EVALUATION OF SATISFACTION, SPECTACLE INDEPENDENCE AND VISION OUTCOMES IN GERMAN PATIENTS IMPLANTED WITH A NOVEL WAVEFRONT-SHAPING PRESBYOPIA-CORRECTING IOL
Published 2022
- 26th ESCRS Winter Meeting
Reference: P015
| Type: Abstracts
| DOI:
10.82333/y8y6-ye91
Authors:
Detlev Breyer* 1
, Caridad Perez-Vives 2
1Breyer-Kaymak-Klabe Eye Surgery & premium Eyes, Düsseldorf,Breyer-Kaymak-Klabe Eye Surgery & premium Eyes, Düsseldorf,Düsseldorf,Germany, 2Global Medical Affairs, Medical Strategy & Publications,Alcon Research, LLC,Forth Worth, Texas,United States
Purpose
To report Real World patient satisfaction, spectacle independence, visual disturbances and vision outcomes with the AcrySof IQ Vivity and AcrySof IQ Vivity Toric Extended Vision IOL models DFT015, DFT315, DFT415, and DFT515 in German patients evaluated through routine clinical practice.
Setting
Multicenter, ambispective registry study conducted in Europe, the UK and Australia evaluating the performance of bilaterally implanted AcrySof IQ Vivity and AcrySof IQ Vivity Toric IOL in a real world setting through routine clinical practice.
Methods
This is a sub-analysis of subjects enrolled from German sites to date. After a minimum of 3 months post-op follow up per local clinical practice standards, subjects implanted with the AcrySof IQ Vivity and/or AcrySof IQ Vivity Toric IOL underwent subjective vision satisfaction and spectacle independence with validated PROMs questionnaires and patient reports of visual disturbances. We present the first interim analysis of outcomes observed at the enrollment visit to date.
Results
27 subjects were enrolled from four German sites. Mean UCDVA, UCIVA and UCNVA were -0.010±0.102, 0.088±0.117 and 0.212±0.150 logMAR, respectively. The need to wear glasses was low with subjects reporting never/rarely needing to wear eyeglasses in bright light to see up close 61.5%, at arm’s length 84.6% or far away 88.4%. 92% were satisfied with their sight, and 88.5% reported no difficulty seeing to engage in an activity/hobby of their interest. Visual disturbances rates were low – reported “None” for halos 92.3%, glare 84.6% or starbursts 96.2%. There are no unanticipated AEs to date.
Conclusion
In this first Real World assessment of patients bilaterally implanted in Germany with the AcrySof IQ Vivity and AcrySof IQ Vivity Toric Extended Vision IOL suggests high levels of post-operative patient satisfaction with low needs to wearing spectacles and experiencing mild to no visual disturbances.